Tag: investor relations

New plan combines Sunrun Flex™ solar + storage with a customized Tesla Electric retail plan to deliver lower rates, seamless backup, and peace of mind for Texas homeowners

TROY, Mich., July 24, 2025 (GLOBE NEWSWIRE) -- Kelly, a leading global specialty talent solutions provider, will release its second-quarter earnings before the market opens on Thursday, August 7, 2025. In conjunction with its earnings release, Kelly will publish a financial presentation and host a live webcast of a conference call with financial analysts at 9 a.m. ET on August 7 to review the results from the quarter and answer questions.

LUXEMBOURG, July 24, 2025 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, today reported financial results for the second quarter 2025.

Common Equity Tier 1 Capital Ratio of 14.13% | Tangible Book Value per Share of $24.33

CHANTILLY, Va., July 24, 2025 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that the company’s joint venture (JV) with Versar was awarded a $75 million single award delivery order contract by the United States Army Corps of Engineers (USACE) Middle East District for construction phase support services (CPSS). The contract includes a three-year base period of performance and a two-year option period. Parsons serves as the JV managing partner.

SAN DIEGO, July 24, 2025 (GLOBE NEWSWIRE) -- Beam Global, (Nasdaq: BEEM), a leading provider of innovative and sustainable infrastructure solutions for the electrification of transportation and energy security, today announced a 21% increase in energy storage solutions (ESS) revenue in the first half of 2025 vs. 2024. Additionally, a purchase order was received from one of its largest ESS customers, for approximately $2 million, scheduled to be recognized as revenue by the end of 2025. The surge reflects Beam Global’s growing role as a trusted ESS supplier for mission-critical energy storage applications and the Company views repeat customers purchasing in increasing volumes as a strong validation of the reliability of its products.

Carlsbad, CA, July 23, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced an agreement between the Company and several accredited investors to exercise certain existing warrants (the “Existing Warrants”) to purchase up to an aggregate of 4,318,905 shares of common stock. The Existing Warrants had adjusted exercise prices of $1.40 and were issued by the Company on May 10, 2022; February 1, 2024; May 6, 2024; and December 13, 2024, with each exercise occurring at a reduced exercise price of $0.9047 per share.

NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES, OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW